Legal & General Group PLC Regeneron Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 959,127 shares of REGN stock, worth $710 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
959,127
Previous 959,127 -0.0%
Holding current value
$710 Million
Previous $1.01 Billion -0.0%
% of portfolio
0.21%
Previous 0.21%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $19.4 Million - $22.8 Million
-18,982 Reduced 1.94%
959,127 $1.01 Billion
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $148,377 - $179,959
168 Added 0.02%
978,109 $1.03 Billion
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $6.86 Million - $7.55 Million
-7,599 Reduced 0.77%
977,941 $941 Million
Q4 2023

Feb 15, 2024
BUY
$775.18 - $881.7 $128 Million - $146 Million
165,332 Added 20.16%
985,540 $866 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $18.6 Million - $22.7 Million
-26,921 Reduced 3.18%
820,208 $675 Million
Q2 2023

Aug 14, 2023
SELL
$700.03 - $830.35 $1.4 Million - $1.66 Million
-1,998 Reduced 0.24%
847,129 $609 Million
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $12.1 Million - $14.7 Million
17,758 Added 2.14%
849,127 $698 Million
Q4 2022

Feb 14, 2023
SELL
$705.89 - $766.39 $29.4 Million - $31.9 Million
-41,616 Reduced 4.77%
831,369 $600 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $5.91 Million - $7.46 Million
-10,302 Reduced 1.17%
872,985 $601 Million
Q2 2022

Aug 22, 2022
BUY
$548.35 - $738.84 $41.3 Million - $55.7 Million
75,391 Added 9.33%
883,287 $522 Million
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $34.2 Million - $40.1 Million
57,387 Added 7.65%
807,896 $564 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $8.48 Million - $10.5 Million
-15,609 Reduced 2.04%
750,509 $474 Million
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $12.1 Million - $14.3 Million
21,066 Added 2.83%
766,118 $464 Million
Q2 2021

Aug 12, 2021
BUY
$472.8 - $558.54 $17.2 Million - $20.3 Million
36,408 Added 5.14%
745,052 $416 Million
Q1 2021

May 17, 2021
SELL
$446.73 - $548.2 $6.51 Million - $7.99 Million
-14,582 Reduced 2.02%
708,644 $335 Million
Q4 2020

Feb 12, 2021
BUY
$478.3 - $607.98 $19.1 Million - $24.3 Million
39,979 Added 5.85%
723,226 $349 Million
Q3 2020

Nov 13, 2020
SELL
$544.75 - $658.21 $5 Million - $6.04 Million
-9,181 Reduced 1.33%
683,247 $382 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $77.9 Million - $102 Million
157,929 Added 29.55%
692,428 $432 Million
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $4.1 Million - $6.03 Million
12,205 Added 2.34%
534,499 $261 Million
Q4 2019

Feb 13, 2020
BUY
$274.13 - $376.51 $5.79 Million - $7.95 Million
21,108 Added 4.21%
522,294 $196 Million
Q3 2019

Nov 13, 2019
BUY
$273.46 - $318.39 $2 Million - $2.33 Million
7,319 Added 1.48%
501,186 $139 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $4.62 Million - $6.39 Million
15,410 Added 3.22%
493,867 $155 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $35 Million - $41.3 Million
93,957 Added 24.44%
478,457 $196 Million
Q4 2018

Feb 15, 2019
BUY
$335.82 - $403.04 $8.23 Million - $9.87 Million
24,498 Added 6.8%
384,500 $144 Million
Q3 2018

Nov 20, 2018
BUY
$351.14 - $408.51 $3.09 Million - $3.59 Million
8,792 Added 2.5%
360,002 $145 Million
Q2 2018

Aug 10, 2018
SELL
$284.6 - $344.99 $3.92 Million - $4.75 Million
-13,767 Reduced 3.77%
351,210 $121 Million
Q1 2018

May 17, 2018
BUY
$315.82 - $393.78 $1.09 Million - $1.35 Million
3,437 Added 0.95%
364,977 $126 Million
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $130 Million - $170 Million
361,540
361,540 $136 Million

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email